Eduardo Salido

8PUBLICATIONS
47CO-AUTHORS
Medical biochemistry - proteins and peptides (incl. medical proteomics)Metabolic medicineMolecular targetsGene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 14, 2026
Impact of Ser81 phosphorylation on alanine: glyoxylate aminotransferase associated with Primary hyperoxaluria type I.

Sara Milosevic, Eduardo Salido, Noel Mesa-Torres

|Sep 27, 2024
Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis.

Sandeep Das, Alexandra C Finney, Sumit Kumar Anand

|May 28, 2022
Targeting HIF-1α Function in Cancer through the Chaperone Action of NQO1: Implications of Genetic Diversity of NQO1.

Eduardo Salido, David J Timson, Isabel Betancor-Fernández

|Jan 30, 2021
Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias.

Maria Dolores Moya-Garzon, Jose Antonio Gomez-Vidal, Alfonso Alejo-Armijo

|Dec 22, 2018
CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I.

Nerea Zabaleta, Miren Barberia, Cristina Martin-Higueras

|Jul 21, 2018
Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1.

María Dolores Moya-Garzón, Cristina Martín Higueras, Pablo Peñalver

Pageof 2